ML 18
ML18 is Bombesin receptor subtype 3 (BRS-3) antagonist (IC50 = 4.8 μM) . ML-18 inhibits lung cancer growth. ML-18 inhibited the proliferation of lung cancer cells. ML-18 is a nonpeptide BRS-3 antagonist that should serve as a template to improve potency and selectivity.
Product Specifications
CAS Number
1422269-30-4
Product Name Alternative
ML-18 | ML 18 | ML18
Purity
>98% (HPLC)
Solubility
DMSO : ≥ 100 mg/mL; 175.55 mM
Smiles
COc1ccc (cc1) C1 (CCCCC1) CNC (=O) [C@H] (Cc1c[nH]c2ccccc12) NC (=O) Nc1ccc (cc1) [N+] (=O) [O-]
Molecular Formula
C32H35N5O5
Molecular Weight
569.65
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
(S) -3- (1H-indol-3-yl) -N- ((1- (4-methoxyphenyl) cyclohexyl) methyl) -2- (3- (4-nitrophenyl) ureido) propanamide
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
N0018-60A-HRP 100 µL
NALP1 (NACHT-, LRR- and PYD-Containing Protein 1, DEFCAP, NAC, CARD7, Caspase Recruitment Domain 7) (HRP) discontinued
Sign In for Pricing
View Details 
bs-15375R-APC-Cy7 100 µL
GPR113 Polyclonal Antibody, APC-Cy7 Conjugated
Sign In for Pricing
View Details